Clinical Trial Update: Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients

View source ↗

Summary

A clinical trial examined whether the p16 gene can predict chemotherapy-induced myelosuppression in breast cancer patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Breast Cancer | Status: COMPLETED